|
ZFP28 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.13800097018202E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.34020025580151E-10 |
| Normal-vs-Stage2 |
8.95299945291583E-10 |
| Normal-vs-Stage3 |
4.09672296086683E-14 |
| Normal-vs-Stage4 |
4.10870226730253E-11 |
| Stage1-vs-Stage2 |
5.060800E-01 |
| Stage1-vs-Stage3 |
7.649500E-02 |
| Stage1-vs-Stage4 |
1.911980E-01 |
| Stage2-vs-Stage3 |
5.387800E-01 |
| Stage2-vs-Stage4 |
5.867400E-01 |
| Stage3-vs-Stage4 |
9.446600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.40689690400586E-11 |
| Normal-vs-AfricanAmerican |
1.86469999996497E-06 |
| Normal-vs-Asian |
9.48179999959997E-07 |
| Caucasian-vs-AfricanAmerican |
9.950200E-01 |
| Caucasian-vs-Asian |
9.463800E-02 |
| AfricanAmerican-vs-Asian |
2.729600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.68780014806214E-10 |
| Normal-vs-Female |
1.89630533498075E-11 |
| Male-vs-Female |
3.308600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.8332004237418E-10 |
| Normal-vs-Age(41-60Yrs) |
3.33066907387547E-15 |
| Normal-vs-Age(61-80Yrs) |
4.73310279858197E-12 |
| Normal-vs-Age(81-100Yrs) |
7.360700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.425600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.546300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.516000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.968400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.417200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.976800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.279400E-03 |
| Classical-VS-Follicular |
2.807800E-02 |
| Classical-VS-Other |
8.475600E-01 |
| Classical-VS-Normal |
5.31489996458134E-09 |
| Tall-VS-Follicular |
2.537000E-01 |
| Tall-VS-Other |
3.018400E-01 |
| Tall-VS-Normal |
1.31820110382819E-11 |
| Follicular-VS-Other |
3.868200E-01 |
| Follicular-VS-Normal |
9.3197005668344E-11 |
| Other-VS-Normal |
2.192200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.7715611723761E-16 |
| Normal-vs-N1 |
3.83939999792915E-08 |
| N0-vs-N1 |
3.267600E-01 |
|
|
